At the time of writing, Medpace Holdings Inc [MEDP] stock is trading at $447.49, down -1.80%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The MEDP shares have gain 43.49% over the last week, with a monthly amount glided 43.82%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Medpace Holdings Inc [NASDAQ: MEDP] stock has seen the most recent analyst activity on July 23, 2025, when TD Cowen downgraded its rating to a Sell but kept the price target unchanged to $366 for it. Previously, Barclays started tracking the stock with Equal Weight rating on June 24, 2025, and set its price target to $300. On April 22, 2025, downgrade downgraded it’s rating to Mkt Perform. TD Cowen downgraded its rating to a Hold but stick to its price target of $328 on April 14, 2025. Leerink Partners initiated its recommendation with a Market Perform and recommended $330 as its price target on March 24, 2025. Robert W. Baird downgraded its rating to Neutral for this stock on October 23, 2024, and downed its price target to $349. In a note dated October 14, 2024, Redburn Atlantic initiated an Buy rating.
For the past year, the stock price of Medpace Holdings Inc fluctuated between $250.05 and $501.30. Currently, Wall Street analysts expect the stock to reach $330 within the next 12 months. Medpace Holdings Inc [NASDAQ: MEDP] shares were valued at $447.49 at the most recent close of the market. An investor can expect a potential drop of -26.26% based on the average MEDP price forecast.
Analyzing the MEDP fundamentals
According to Medpace Holdings Inc [NASDAQ:MEDP], the company’s sales were 2.23B for trailing twelve months, which represents an 14.24% jump. Gross Profit Margin for this corporation currently stands at 0.32% with Operating Profit Margin at 0.21%, Pretax Profit Margin comes in at 0.22%, and Net Profit Margin reading is 0.19%. To continue investigating profitability, this company’s Return on Assets is posted at 0.27, Equity is 0.68 and Total Capital is 1.36. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.72.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 433.25 points at the first support level, and at 419.00 for the second support level. However, for the 1st resistance point, the stock is sitting at 455.76, and for the 2nd resistance point, it is at 464.03.
Ratios To Look Out For
It is important to note that Medpace Holdings Inc [NASDAQ:MEDP] has a current ratio of 0.43. As well, the Quick Ratio is 0.43, while the Cash Ratio is 0.04. Considering the valuation of this stock, the price to sales ratio is 5.63, the price to book ratio is 72.75 and price to earnings (TTM) ratio is 33.28.
Transactions by insiders
Recent insider trading involved Brady Kevin M., Officer, that happened on Jul 24 ’25 when 12000.0 shares were purchased. Officer, GEIGER JESSE J completed a deal on Jul 24 ’25 to buy 41801.0 shares. Meanwhile, Director DAVENPORT FRED B JR sold 1712.0 shares on Apr 24 ’25.
